BDBM71791 3-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)-N-(2-furanylmethyl)propanamide::3-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)-N-(2-furfuryl)propionamide::3-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)-N-(furan-2-ylmethyl)propanamide::3-(5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)-N-(2-furylmethyl)propanamide::MLS000089630::SMR000027978::cid_3245155

SMILES [2H]C([2H])(O)c1cccc2nc(NC(=O)c3sc4c(C(C)=O)ccc(COC)c4c3C)ccc12

InChI Key InChIKey=JFXWWSBFHGWMOC-ZWGOZCLVSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 71791   

LigandChemical structure of BindingDB Monomer ID 71791BDBM71791(7-Acetyl-N-(5-(hydroxy(2H2)methyl)quinolin-2-yl)-4...)
Affinity DataIC50: 0.340nMpH: 7.5 T: 2°CAssay Description:A human acute lymphoblastic lymphoma T cell line MOLT-4 (which can be purchased under ATCC No. CRL-1582 from ATCC) was cultured in an RPMI1640 medium...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/2/2017
Entry Details
US Patent